Literature DB >> 3565015

An alternative approach to typing of Streptococcus pneumoniae strains by coagglutination.

L E Smart, J Henrichsen.   

Abstract

The coagglutination test, which uses staphylococcal protein A for typing strains of Streptococcus pneumoniae was extended to include typing within 13 groups. Typing was performed using the factors remaining in group antisera after absorption with a strain of a type within the group. 93 of 99 strains of S. pneumoniae, which belonged to one of the 13 groups included in the 23 valent vaccine formulation were correctly identified when compared to the capsular reaction test.

Entities:  

Mesh:

Year:  1986        PMID: 3565015     DOI: 10.1111/j.1699-0463.1986.tb03076.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand B        ISSN: 0108-0180


  5 in total

1.  Characterization of IS1515, a functional insertion sequence in Streptococcus pneumoniae.

Authors:  R Muñoz; R López; E García
Journal:  J Bacteriol       Date:  1998-03       Impact factor: 3.490

2.  Dot blot assay for the serotyping of pneumococci.

Authors:  A Fenoll; I Jado; D Vicioso; J Casal
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.

Authors:  J M Jefferies; A J Smith; G F S Edwards; J McMenamin; T J Mitchell; S C Clarke
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

4.  Automated pneumococcal MLST using liquid-handling robotics and a capillary DNA sequencer.

Authors:  Johanna Jefferies; Stuart C Clarke; Mathew A Diggle; Andrew Smith; Chris Dowson; Tim Mitchell
Journal:  Mol Biotechnol       Date:  2003-07       Impact factor: 2.860

5.  Utility of MALDI-TOF MS as a new tool for Streptococcus pneumoniae serotyping.

Authors:  María Ercibengoa; Marta Alonso; Diego Vicente; Maria Morales; Ernesto Garcia; Jose María Marimón
Journal:  PLoS One       Date:  2019-02-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.